Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Protocol of the Combination of Bortezomib and Tipifarnib for Relapsed or Refractory Multiple Myeloma
#844235
ClinicalTrials.gov
Weekly Bortezomib (Velcade) in the Treatment of Patients With Refractory Multiple Myeloma
#846451
ClinicalTrials.gov
Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients
#853667
ClinicalTrials.gov
Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
#855314
ClinicalTrials.gov
A Phase I Study of Lintuzumab-Ac225 in Patients With Refractory Multiple Myeloma
#856250
ClinicalTrials.gov
BCMA CAR-T for Dynamic High-risk Multiple Myeloma
#862559
ClinicalTrials.gov
Aponermin, Pomalidomide, Dexamethasone for Patients With Relapsed/ Refractory Multiple Myeloma
#913396
ClinicalTrials.gov
A Clinical Study of SHR-9539 in Patients With Multiple Myeloma
#914160
ClinicalTrials.gov
Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma
#982537
ClinicalTrials.gov
A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat
#982678
ClinicalTrials.gov
Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
#887223
ClinicalTrials.gov
Daratumumab, VELCADE (Bortezomib), Lenalidomide and Dexamethasone Compared to VELCADE, Lenalidomide and Dexamethasone in Subjects With Previously Untreated Multiple Myeloma
#904669
ClinicalTrials.gov
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
#849497
ClinicalTrials.gov
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.
#889295
ClinicalTrials.gov
All-trans Retinoic Acid in Combination With a KPD Regimen for the Treatment of Refractory/Relapsed Multiple Myeloma
#891633
ClinicalTrials.gov
Study to Compare VMP With HDM Followed by VRD Consolidation and Lenalidomide Maintenance in Patients With Newly Diagnosed Multiple Myeloma
#848516
ClinicalTrials.gov
Ixazomib (MLN9708) and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
#859344
ClinicalTrials.gov
Inobrodib, Pomalidomide and Dexamethasone Versus Standard Available Therapy in Relapsed or Refractory Multiple Myeloma
#877111
ClinicalTrials.gov
Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma
#917139
ClinicalTrials.gov
Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma
#980132
ClinicalTrials.gov
Once-weekly Versus Twice-weekly Carfilzomib in Combination With Dexamethasone in Adults With Relapsed and Refractory Multiple Myeloma
#140989
ClinicalTrials.gov
A Study of BCMA/CD19 Dual-Target CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
#226278
ClinicalTrials.gov
Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma
#411246
ClinicalTrials.gov
Phase 3 Study of Carfilzomib, Melphalan, Prednisone vs Bortezomib, Melphalan, Prednisone in Newly Diagnosed Multiple Myeloma
#811131
ClinicalTrials.gov
A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
#828118
ClinicalTrials.gov
Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
#828953
ClinicalTrials.gov
Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)
#831009
ClinicalTrials.gov
A Study of C-CAR088 in Patients With Relapsed or Refractory Multiple Myeloma
#839199
ClinicalTrials.gov
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
#844097
ClinicalTrials.gov
Treatment Optimization in Patients With Untreated Multiple Myeloma
#867048
ClinicalTrials.gov
Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma
#875874
ClinicalTrials.gov
Clarithromycin, Sulfamethoxazole/Trimethoprim or Observation in Newly Diagnosed Multiple Myeloma
#879057
ClinicalTrials.gov
Improving the Quality of Multiple Myeloma Treatment With Patient Care Plans
#886812
ClinicalTrials.gov
A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Multiple Myeloma
#888775
ClinicalTrials.gov
Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive
#902405
ClinicalTrials.gov
Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma
#993852
ClinicalTrials.gov
Non-interventional Study on Salvage Auto in Relapsed Myeloma
#993598
ClinicalTrials.gov
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
#800732
ClinicalTrials.gov
Feasibility, Safety and Effectivity of an Exercise Intervention for Newly Diagnosed Multiple Myeloma Patients During Induction Therapy
#813061
ClinicalTrials.gov
Study of Ibrutinib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
#874941
ClinicalTrials.gov
Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
#238151
ClinicalTrials.gov
Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies
#810799
ClinicalTrials.gov
CTFEA Myeloma Study
#908958
ClinicalTrials.gov
Study of Elranatamab for Relapsed or Refractory Myeloma in Patients Previously Exposed to Three-drug Classes
#917435
ClinicalTrials.gov
FT576 in Subjects With Multiple Myeloma
#902434
ClinicalTrials.gov
CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
#253055
ClinicalTrials.gov
Safety and Efficacy of CS1 CAR-T (WS-CART-CS1) in Subjects With Multiple Myeloma
#349953
ClinicalTrials.gov
Immunotherapy With BCMA CAR-T Cells in Treating Patients With Relapsed or Refractory Multiple Myeloma
#366578
ClinicalTrials.gov
A Clinical Study of CT0596 CAR-T in Relapsed/Refractory Multiple Myeloma
#834586
ClinicalTrials.gov
RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma
#842649
ClinicalTrials.gov
← Previous
Page 5 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.